| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Lepu Medical Technology (Beijing) Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥16.30 |
| 52 Week High | CN¥0 |
| 52 Week Low | CN¥0 |
| Beta | 0.052 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 28.35% |
Recent News & Updates
Recent updates
Shareholder Returns
| LEPU | CH Medical Equipment | CH Market | |
|---|---|---|---|
| 7D | 0% | -0.3% | 0.1% |
| 1Y | 0% | 5.0% | -3.2% |
Return vs Industry: LEPU underperformed the Swiss Medical Equipment industry which returned 5% over the past year.
Return vs Market: LEPU exceeded the Swiss Market which returned -3.2% over the past year.
Price Volatility
| LEPU volatility | |
|---|---|
| LEPU Average Weekly Movement | 0% |
| Medical Equipment Industry Average Movement | 3.8% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in CH Market | 7.2% |
| 10% least volatile stocks in CH Market | 2.0% |
Stable Share Price: LEPU has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine LEPU's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 10,652 | Zhi Bin Zhang | www.lepumedical.com |
Lepu Medical Technology (Beijing) Co., Ltd. engages in the development, manufacture, and distribution of medical devices and equipment worldwide. The company offers peripheral interventional products, including Supercross PTA balloon dilatation catheters and Angiocide peripheral cutting balloons; and cardiovascular products, such as coronary stents and balloons, catheters, guide wires, introducer sheaths, fractional flow reserves, and accessories.
Lepu Medical Technology (Beijing) Co., Ltd. Fundamentals Summary
| LEPU fundamental statistics | |
|---|---|
| Market cap | US$3.68b |
| Earnings (TTM) | US$157.76m |
| Revenue (TTM) | US$1.03b |
23.3x
P/E Ratio3.6x
P/S RatioIs LEPU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LEPU income statement (TTM) | |
|---|---|
| Revenue | CN¥7.46b |
| Cost of Revenue | CN¥2.81b |
| Gross Profit | CN¥4.65b |
| Other Expenses | CN¥3.51b |
| Earnings | CN¥1.14b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.62 |
| Gross Margin | 62.32% |
| Net Profit Margin | 15.31% |
| Debt/Equity Ratio | 26.5% |
How did LEPU perform over the long term?
See historical performance and comparison